Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (30)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Maffia, A. M.
Right arrow Articles by Oldenburg, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maffia, A. M., III
Right arrow Articles by Oldenburg, K. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Miniaturization of a Mammalian Cell-Based Assay: Luciferase Reporter Gene Readout in a 3 Microliter 1536-Well Plate

Anthony M. Maffia, III

DuPont Pharmaceuticals Company, Wilmington, DE

Ilona Kariv

DuPont Pharmaceuticals Company, Wilmington, DE

Kevin R. Oldenburg

DuPont Pharmaceuticals Company, Wilmington, DE

The combined efforts of the fields of combinatorial chemistry and genomics have significantly increased the number of compounds and therapeutic targets available for screening. The number of compounds will reach into the million range in the near future and provide vast chemical diversity for drug discovery. However, this reservoir of chemical diversity creates downstream hurdles for any screening effort. Properly examining this number of compounds increases investments dramatically, both in the number of dollars spent and amount of limited reagents depleted. Traditional HTS techniques, such as the use of 96-well microtiter plates, have paved the way for faster processing speeds, but are being rapidly overwhelmed by screening demands. Miniaturization of such assays will allow for greater throughput, while concurrently reducing cost. To date, miniaturization efforts have been most successfully applied to bacterial and soluble protein based assays. Questions about the ability to deliver microquantities of mammalian cells without disruption of the cell membrane and/or activation of stress responses have been raised. An assay has been developed in which a human T-cell screen has been adapted to a 1536-well plate format. Through the use of a luciferase reporter gene system, it is shown that a mammalian cell-based assay may be successfully performed in 3 pil and potent inhibitors of the target of interest identified.

Journal of Biomolecular Screening, Vol. 4, No. 3, 137-142 (1999)
DOI: 10.1177/108705719900400307


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
P. B. Taylor, S. Ashman, S. M. Baddeley, S. L. Bartram, C. D. Battle, B. C. Bond, Y. M. Clements, N. J. Gaul, W. E. McAllister, J. A. Mostacero, et al.
A Standard Operating Procedure for Assessing Liquid Handler Performance in High-Throughput Screening
J Biomol Screen, December 1, 2002; 7(6): 554 - 569.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
G. Sorg, H.-D. Schubert, F. H. Buttner, and R. Heilker
Automated High Throughput Screening for Serine Kinase Inhibitors Using a LEADSeekerTM Scintillation Proximity Assay in the 1536-Well Format
J Biomol Screen, February 1, 2002; 7(1): 11 - 19.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
I. Kariv, H. Cao, P. D. Marvil, E. V. Bobkova, Y. E. Bukhtiyarov, Y. P. Yan, U. Patel, L. Coudurier, T. D.Y. Chung, and K. R. Oldenburg
Identification of Inhibitors of Bacterial Transcription/Translation Machinery Utilizing a Miniaturized 1536-Well Format Screen
J Biomol Screen, August 1, 2001; 6(4): 233 - 243.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
M. Klumpp, A. Scheel, E. Lopez-Calle, M. Busch, K. J. Murray, and A. J. Pope
Ligand Binding to Transmembrane Receptors on Intact Cells or Membrane Vesicles Measured in a Homogeneous 1-Microliter Assay Format
J Biomol Screen, June 1, 2001; 6(3): 159 - 170.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
I. Kariv, M. P. Fereshteh, and K. R. Oldenburg
Development of a Miniaturized 384-Well High Throughput Screen for the Detection of Substrates of Cytochrome P450 2D6 and 3A4 Metabolism
J Biomol Screen, April 1, 2001; 6(2): 91 - 99.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
M. Berg, K. Undisz, R. Thiericke, P. Zimmermann, T. Moore, and C. Posten
Evaluation of Liquid Handling Conditions in Microplates
J Biomol Screen, February 1, 2001; 6(1): 47 - 56.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
M. Berg, K. Undisz, R. Thiericke, T. Moore, and C. Posten
Miniaturization of a Functional Transcription Assay in Yeast (Human Progesterone Receptor) in the 384- and 1536-Well Plate Format
J Biomol Screen, April 1, 2000; 5(2): 71 - 76.
[Abstract] [PDF]


Home page
J Biomol ScreenHome page
Z. Li, S. Mehdi, I. Patel, J. Kawooya, M. Judkins, W. Zhang, K. Diener, A. Lozada, and D. Dunnington
An Ultra-High Throughput Screening Approach for an Adenine Transferase Using Fluorescence Polarization
J Biomol Screen, February 1, 2000; 5(1): 31 - 37.
[Abstract] [PDF]